S100A4 and cancer: Since Cisplatin promoted cancer cell death and inhibited cell viability by inducing DNA double-strand break (DSB) [29, 30], and p53 was the hub gene of DSB-induced cell death [31], it was reasonable to hypothesize that S100A4/p53 axis was crucial for regulating Cisplatin-resistance of CC cells.